Resolving complex biology at the single cell level is crucial to the understanding of disease, and ultimately unlocking novel therapies. While advances have been made in precision medicine, challenges in fully understanding disease profiles at the clonal level still remain. Clinicians and drug developers require better tools to unravel the complex heterogeneity underlying disease progression, treatment response, and therapeutic resistance. In this webinar, Dr. Todd Druley, Chief Medical Officer from Mission Bio, will give an overview of the needs and challenges of precision medicine from a clinical perspective. Then, Blake Alexander, Senior Director, Biopharma Business Development, will present the economic values of employing a single cell technology for better patient stratification with case studies and the path to enablement.